1288342-41-5

Upstream product

• 1288339-30-9 3,5-dicyclopropyl-1H-pyrazole 
• 1288339-37-6 4-(3,5-dicyclopropyl-1H-pyrazol-1-yl)aniline 
• 1288339-31-0 3,5-dicyclopropyl-1-(4-nitrophenyl)-1H-pyrazole 
• 110-85-0 piperazine 
• 1288339-42-3 2-chloro-N-[4-(3,5-dicyclopropyl-1H-pyrazol-1-yl)phenyl]acetamide 
• 30923-64-9 1,3-dicyclopropylpropane-1,3-dione 
• 765-43-5 Cyclopropyl methyl ketone 

Downstream Products

• 1288341-00-3 tert-butyl 4-(2-(4-(3,5-dicyclopropyl-1H-pyrazol-1-yl)phenylamino)-2-oxoethyl)piperazine-1-carboxylate 
• 1288340-99-7 N-[4-(3,5-dicyclopropyl-1H-pyrazol-1-yl)phenyl]-2-(piperazin-1-yl)acetamide hydrochloride 

Relevant academic research and scientific papers

PYRAZOLE DERIVATIVES AS MODULATORS OF CALCIUM RELEASE -ACTIVATED CALCIUM CHANNEL

Disclosed are novel calcium release-activated calcium (CRAC) channel inhibitors, methods for preparing them, pharmaceutical compositions containing them, and methods of treatment using them. The present disclosure also relates to methods for treating non-small cell lung cancer (NSCLC) with CRAC inhibitors, and to methods for identifying therapeutics for treating and of diagnosing cancer.